Beyond Instagram: Introducing the next generation of social apps

These newer social apps offer alternatives to Big Tech’s feeds, focusing on interests, creativity, and community.

The Trump administration might take an equity stake in OpenAI

President Donald Trump said he’s discussing deals “where the American people can benefit from the success of AI.”

Sriram Krishnan is leaving his role as White House AI advisor

Krishnan is reportedly starting a new institution to continue shaping Trump’s AI policy.

OpenAI unveils Lockdown Mode to protect sensitive data from prompt injection attacks

Even with Lockdown Mode, ChatGPT could be still vulnerable to prompt injections, but the goal is to reduce the likelihood that sensitive data gets shared in the process.

What to expect from WWDC 2026: Siri’s highly anticipated revamp and Apple Intelligence updates

Apple’s WWDC nears: Here’s what you can look forward to.

Google will pay SpaceX $920M per month for compute

In a statement, a Google representative described the deal as a result of unexpected demand for its recently launched AI products.

Startup Battlefield 200 applications officially close in 3 days

Applications for Startup Battlefield 200 officially close on June 8, 11:59 p.m. PT. Don’t wait any longer. Secure your shot at competing on the Disrupt Stage at TechCrunch Disrupt 2026 this October at San Francisco’s Moscone West.

Founders share VC horror stories, and some are naming names

A massive viral conversation sharing VC horror stories has taken place this week on X. Some are weird. Some are infuriating.

Former cyber executive turned whistleblower accuses IBM of covering up several data breaches

IBM and two of its subsidiary companies were allegedly breached during the mid-2010s — a lawsuit filed by a former cybersecurity executive accuses IBM of not disclosing and actively covering it up.

Reid Hoffman is leaving Microsoft’s board to go ‘founder mode’ with startup Manus

After a very profitable decade on Microsoft’s board, Reid Hoffman is stepping down to focus on his AI drug discovery startup Manus.